Dow Jones Industrial Average Recovers On Boeing, Data

After plunging more than 100 points at the open on a negative earnings reaction for tech stock Apple Inc. (NASDAQ:AAPL), the Dow Jones Industrial Average (DJIA) spent the remainder of the session clawing its way north. Despite crude oil's continued sell-off, the Dow won the day, thanks to relatively upbeat economic data and a strong post-earnings performance for Boeing Co (NYSE:BA). Nevertheless, AAPL's loss was too much for the S&P 500 Index (SPX) and Nasdaq Composite (COMP), which both settled the session in the red.

Continue reading for more on today's market, including:

• 3 charts pointing to rising pre-election fear.
• While Lululemon Athletica inc. (NASDAQ:LULU) took off amid takeover chatter, Under Armour Inc (NYSE:UA) tripped on negative analyst attention.
• A blowout earnings report had option buyers sucking up calls for this trendy vacuum maker.
• Plus... The soaring semiconductor stock that could have room to run, why Edwards Lifesciences slumped, and Akamai Technologies' big day.
  

The Dow Jones Industrial Average (DJIA - 18,199.33) managed a win of 30.1 points, or 0.2%. BA led the 16 Dow winners, tacking on 4.7%, while the 14 decliners were paced by AAPL's 2.3% drop.

The S&P 500 Index (SPX – 2,139.43) dropped 3.7 points, or 0.2%, while the Nasdaq Composite (COMP – 5,250.27) lost 33.1 points, or 0.6%.

The CBOE Volatility Index (VIX – 14.24) rose 0.8 point, or 5.8%.

5 Items on Our Radar Today

1. In a move that could stall future sales for Apple, some Chinese iPhone owners are choosing to give their old phones a new look, instead of opting to upgrade. Rather than shelling out cash for a replacement, many consumers are replacing their phone back plates, installing headphone jack plugs, and purchasing other accessories to make their old iPhones look like the newest iteration. (Reuters)
2. Pharmaceutical company Kaleo will be bringing its EpiPen competitor, Auvi-Q, back to the market after removing it due to manufacturing issues last year. Although offering no details for its pricing structure, Kaleo insists that out-of-pocket costs for Auvi-Q patients will be low. Rival Mylan NV (NASDAQ:MYL) came under pressure earlier this year for price gouging its EpiPen. (Forbes)
3. The semiconductor stock that's more than doubled this year -- and, much to skeptics' dismay, could have room to run.
4. Analysts were quick to change their tune on Edwards Lifesciences Corp (NYSE:EW), which got stomped after earnings.
5. What sent cloud concern Akamai Technologies Inc. (NASDAQ:AKAM) to its highest perch of the year.

Data courtesy of Trade-Alert

Commodities:

December-dated crude futures dropped 78 cents, or 1.6%, to $49.18 per barrel, as anxiety over the Organization of the Petroleum Exporting Countries' (OPEC) proposed output cut overshadowed a surprise drop in domestic crude inventories. 

Gold for December delivery slipped $7, or 0.6%, to end the day at $1,266.60 per ounce, as traders turned their attention to next week's Federal Open Market Committee (FOMC) policy-setting meeting.